<DOC>
	<DOC>NCT01716221</DOC>
	<brief_summary>The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.</brief_summary>
	<brief_title>An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia</brief_title>
	<detailed_description>This is a double blind study with a single subject to objectively document the clinical effects of bupropion and citalopram in a single patient with Friedreich Ataxia (FA), whose disorder symptoms have improved with the use of these medications.</detailed_description>
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Friedreich Ataxia Unable to provide Informed Consent</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>